BioNexus Gene Lab Corp (BGLC) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $637.9K | -69.8% |
| 2024 | $2.11M | +21.2% |
| 2023 | $1.74M | -16.1% |
| 2022 | $2.08M | -13.3% |
| 2021 | $2.39M | -30.7% |
| 2020 | $3.45M | +3071.7% |
| 2019 | $108.9K | -16.5% |
| 2018 | $130.3K | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $637.9K | -69.8% |
| 2024 | $2.11M | +21.2% |
| 2023 | $1.74M | -16.1% |
| 2022 | $2.08M | -13.3% |
| 2021 | $2.39M | -30.7% |
| 2020 | $3.45M | +3071.7% |
| 2019 | $108.9K | -16.5% |
| 2018 | $130.3K | — |